These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11856160)

  • 1. p53 and Ki-67 expression as prognostic factors in cystosarcoma phyllodes.
    Erhan Y; Zekioglu O; Ersoy O; Tugan D; Aydede H; Sakarya A; Kapkaç M; Ozdemir N; Ozbal O; Erhan Y
    Breast J; 2002; 8(1):38-44. PubMed ID: 11856160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.
    Esposito NN; Mohan D; Brufsky A; Lin Y; Kapali M; Dabbs DJ
    Arch Pathol Lab Med; 2006 Oct; 130(10):1516-21. PubMed ID: 17090194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features.
    Shpitz B; Bomstein Y; Sternberg A; Klein E; Tiomkin V; Kaufman A; Groisman G; Bernheim J
    J Surg Oncol; 2002 Feb; 79(2):86-92. PubMed ID: 11815995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients.
    Cohn-Cedermark G; Rutqvist LE; Rosendahl I; Silfverswärd C
    Cancer; 1991 Nov; 68(9):2017-22. PubMed ID: 1655234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An approach to malignant mammary phyllodes tumors detection.
    Ilić I; Randelović P; Ilić R; Katić V; Milentijević M; Velicković L; Krstić M
    Vojnosanit Pregl; 2009 Apr; 66(4):277-82. PubMed ID: 19441158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
    Jia C; Mei F; Zheng J; You JF; Liu JY
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.
    Yonemori K; Hasegawa T; Shimizu C; Shibata T; Matsumoto K; Kouno T; Ando M; Katsumata N; Fujiwara Y
    Pathol Res Pract; 2006; 202(10):705-12. PubMed ID: 16889904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
    Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
    J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast.
    Kucuk U; Bayol U; Pala EE; Cumurcu S
    Indian J Pathol Microbiol; 2013; 56(2):129-34. PubMed ID: 24056649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
    Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
    Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary treatment of cystosarcoma phyllodes of the breast.
    Chaney AW; Pollack A; McNeese MD; Zagars GK; Pisters PW; Pollock RE; Hunt KK
    Cancer; 2000 Oct; 89(7):1502-11. PubMed ID: 11013364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53 protein and Ki-67 antigen in phyllodes tumor of the breast.
    Chan YJ; Chen BF; Chang CL; Yang TL; Fan CC
    J Chin Med Assoc; 2004 Jan; 67(1):3-8. PubMed ID: 15077883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki67 and P53 Expression in Relation to Clinicopathological Features in Phyllodes Tumour of the Breast.
    Mohd Ali NA; Nasaruddin AF; Mohamed SS; Wan Rahman WF
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2653-2659. PubMed ID: 32986365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phyllodes tumor (cystosarcoma phyllodes) of the breast. A clinicopathologic study of 45 cases.
    Inoshita S
    Acta Pathol Jpn; 1988 Jan; 38(1):21-33. PubMed ID: 2834912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
    Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
    Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome.
    Feakins RM; Mulcahy HE; Nickols CD; Wells CA
    Histopathology; 1999 Aug; 35(2):162-9. PubMed ID: 10460662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased p53 protein expression in malignant mammary phyllodes tumors.
    Tse GM; Putti TC; Kung FY; Scolyer RA; Law BK; Lau TS; Lee CS
    Mod Pathol; 2002 Jul; 15(7):734-40. PubMed ID: 12118111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour angiogenesis and p53 protein expression in mammary phyllodes tumors.
    Tse GM; Lui PC; Scolyer RA; Putti TC; Kung FY; Law BK; Lau TS; Lee CS
    Mod Pathol; 2003 Oct; 16(10):1007-13. PubMed ID: 14559983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 protein expression and gene mutation in phyllodes tumors of the breast.
    Gatalica Z; Finkelstein S; Lucio E; Tawfik O; Palazzo J; Hightower B; Eyzaguirre E
    Pathol Res Pract; 2001; 197(3):183-7. PubMed ID: 11314782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
    Kleer CG; Giordano TJ; Braun T; Oberman HA
    Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.